INM-005

N/A

Report date: 2025/12/30 20:00:13

Base Information

Drug NameINM-005
Drug Alias NameCoviFabINM005INM-005
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionVirus replication inhibitorsVirus internalization inhibitorsImmunoglobulin agonists
TargetsImmunoglobulin
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryArgentina
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInmunova Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInmunova Sa
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A